chr12-18696210-T-A

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_033123.4(PLCZ1):​c.1231A>T​(p.Thr411Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000125 in 1,602,284 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 17/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.000013 ( 0 hom., cov: 27)
Exomes 𝑓: 0.000012 ( 0 hom. )

Consequence

PLCZ1
NM_033123.4 missense

Scores

1
18

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 1.07

Publications

3 publications found
Variant links:
Genes affected
PLCZ1 (HGNC:19218): (phospholipase C zeta 1) The protein encoded by this gene is a member of the phosphoinositide-specific phospholipase C family. Members in this family, classified into six isotypes that are tissue- and organ-specific, hydrolyze phosphatidylinositol 4,5-bisphosphate just before the phosphate group to yield diacylglycerol and inositol 1,4,5-trisphosphate. This protein localizes to the acrosome in spermatozoa and elicits Ca(2+) oscillations and egg activation during fertilization that leads to early embryonic development. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2012]
PIK3C2G (HGNC:8973): (phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 gamma) The protein encoded by this gene belongs to the phosphoinositide 3-kinase (PI3K) family. PI3-kinases play roles in signaling pathways involved in cell proliferation, oncogenic transformation, cell survival, cell migration, and intracellular protein trafficking. This protein contains a lipid kinase catalytic domain as well as a C-terminal C2 domain, a characteristic of class II PI3-kinases. C2 domains act as calcium-dependent phospholipid binding motifs that mediate translocation of proteins to membranes, and may also mediate protein-protein interactions. This gene may play a role in several diseases, including type II diabetes. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2014]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.10454321).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PLCZ1NM_033123.4 linkc.1231A>T p.Thr411Ser missense_variant Exon 11 of 15 ENST00000266505.12 NP_149114.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PLCZ1ENST00000266505.12 linkc.1231A>T p.Thr411Ser missense_variant Exon 11 of 15 1 NM_033123.4 ENSP00000266505.7 Q86YW0-1
PLCZ1ENST00000648272.1 linkc.1354A>T p.Thr452Ser missense_variant Exon 10 of 14 ENSP00000497636.1 A0A3B3ISW9
PLCZ1ENST00000539875.5 linkc.652A>T p.Thr218Ser missense_variant Exon 7 of 11 1 ENSP00000445026.1 Q86YW0-2
PLCZ1ENST00000318197.10 linkn.*1096A>T non_coding_transcript_exon_variant Exon 11 of 15 1 ENSP00000326397.6 F5H474
PLCZ1ENST00000318197.10 linkn.*1096A>T 3_prime_UTR_variant Exon 11 of 15 1 ENSP00000326397.6 F5H474

Frequencies

GnomAD3 genomes
AF:
0.0000132
AC:
2
AN:
151250
Hom.:
0
Cov.:
27
show subpopulations
Gnomad AFR
AF:
0.0000244
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000288
AC:
7
AN:
243448
AF XY:
0.0000381
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000457
Gnomad OTH exome
AF:
0.000168
GnomAD4 exome
AF:
0.0000124
AC:
18
AN:
1450932
Hom.:
0
Cov.:
29
AF XY:
0.0000152
AC XY:
11
AN XY:
721726
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33160
American (AMR)
AF:
0.00
AC:
0
AN:
44254
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25870
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39464
South Asian (SAS)
AF:
0.0000820
AC:
7
AN:
85340
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53062
Middle Eastern (MID)
AF:
0.000349
AC:
2
AN:
5738
European-Non Finnish (NFE)
AF:
0.00000725
AC:
8
AN:
1104186
Other (OTH)
AF:
0.0000167
AC:
1
AN:
59858
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.469
Heterozygous variant carriers
0
2
3
5
6
8
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000132
AC:
2
AN:
151352
Hom.:
0
Cov.:
27
AF XY:
0.00
AC XY:
0
AN XY:
73972
show subpopulations
African (AFR)
AF:
0.0000243
AC:
1
AN:
41100
American (AMR)
AF:
0.00
AC:
0
AN:
15168
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5104
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4802
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10504
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
0.0000147
AC:
1
AN:
67906
Other (OTH)
AF:
0.00
AC:
0
AN:
2098
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
0.0000712
Hom.:
0
ExAC
AF:
0.0000330
AC:
4

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Jun 29, 2023
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.1231A>T (p.T411S) alteration is located in exon 11 (coding exon 10) of the PLCZ1 gene. This alteration results from a A to T substitution at nucleotide position 1231, causing the threonine (T) at amino acid position 411 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.15
BayesDel_addAF
Benign
-0.14
T
BayesDel_noAF
Benign
-0.44
CADD
Benign
15
DANN
Benign
0.94
DEOGEN2
Benign
0.12
.;.;T;.;.
Eigen
Benign
-0.47
Eigen_PC
Benign
-0.37
FATHMM_MKL
Benign
0.62
D
LIST_S2
Benign
0.78
T;T;T;T;T
M_CAP
Benign
0.011
T
MetaRNN
Benign
0.10
T;T;T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.90
.;.;L;.;.
PhyloP100
1.1
PrimateAI
Benign
0.33
T
PROVEAN
Benign
-1.6
.;N;N;N;N
REVEL
Benign
0.055
Sift
Uncertain
0.0060
.;D;T;T;D
Sift4G
Benign
0.41
.;T;T;T;.
Polyphen
0.30, 0.19
.;B;B;.;.
Vest4
0.15, 0.14, 0.17
MVP
0.62
MPC
0.022
ClinPred
0.22
T
GERP RS
3.2
Varity_R
0.076
gMVP
0.16
Mutation Taster
=89/11
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs147366281; hg19: chr12-18849144; API